Journals / Kocatepe Tıp Dergisi / 2014 / Cilt: 15 - Sayı: 2

Antimüllerian Hormon ve İntrauterin İnseminasyon Sikluslarında Ovarian Yanıt: Prospektif Çalışma

Pages
85–91
Publication Date
2014-08-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The AMH was correlated with antral follicle count (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose was to investigate the AMH level and other ovarian reserve markers in the different ovarian response groups.
📊
Key Findings & Data:Material and Methods: 80 patients treated with intrauterine insemination were evaluated who were admitted to the Infertility Clinic, Department of Obstetrics and Gynecology of Ege University between September 2009 and May 2011.
💡
Conclusion & Impact:The AMH was correlated with antral follicle count (p
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Anti-müllerian hormon · over rezervi · infertilite

Abstract

Objective: The purpose was to investigate the AMH level and other ovarian reserve markers in the different ovarian response groups. Material and Methods: 80 patients treated with intrauterine insemination were evaluated who were admitted to the Infertility Clinic, Department of Obstetrics and Gynecology of Ege University between September 2009 and May 2011. According to ovarian response each of the groups were divided as less, normal, more ovarian response subgroups and these subgroups were compared for basal AMH, LH, FSH, E2, PRL, age, number of antral follicles and pregnancy. Results: There was found only statistical difference between duration of infertility when Clomiphene citrate and gonadotropin-given groups were According to low, normal and more ovarian response, there was AMH, FSH, LH, antral folliclecount, age, E2 values. The AMH was correlated with antral follicle count (p

Özet

Amaç: Çalışmamızın amacı, intrauterin inseminasyon sikluslarında, over rezervini değerlendirmede antimüllerian hormon ile diğer rezerv belirteçlerini karşılaştırarak antimüllerian hormonun güvenilirliğinin araştırılmasıdır. Gereç ve Yöntem: Eylül 2009 ile Mayıs 2011 tarihleri arasında Ege Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Kliniği İnfertilite Bölümü’ne başvuran ve intrauterin inseminasyon yapılan 80 hasta değerlendirilmiştir. Bu hastaların 9’unda polikistik over ve hipotalamohipofizer yetmezlik tanısı konulması üzerine çalışma grubuna dahil edilmediler ve çalışmaya dahil edilen 71 hasta klomifen sitrat ve gonadotropin kullanılan hastalar olarak iki gruba ayrıldı. Her iki grup, over yanıtına göre kendi arasında düşük, normal ve fazla over yanıtı olarak ayrılarak gruplar bazal AMH, LH, FSH, E2, PRL, yaş, antral follikül sayısı, gebelik açısından karşılaştırıldı. Bulgular: Klomifen sitrat ve gonadotropin verilen gruplar karşılaştırıldığında sadece infertilite süreleri arasında istatiksel fark saptandı (p

🔖

Cite This Article

DEMİRTAŞ, G. S., DEMİRTAŞ, Ö., ÖZTEKİN, K., ŞENDAĞ, F., BİLGİN, O. (2014). Antimüllerian Hormon ve İntrauterin İnseminasyon Sikluslarında Ovarian Yanıt: Prospektif Çalışma. Kocatepe Tıp Dergisi, Cilt: 15 - Sayı: 2, 85–91. https://ajindex.com/articles/686266

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Doğan DG, Berker B. Over rezervinin değerlendiril- mesi (Evaluation of ovarian reserve). Turkiye Klinikleri J Gynecol Obst 2008;18(4):254-65. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67(5):817–21.
  2. Freiesleben NC, Rosendahl M, Johannsen TH, et al. Prospective investigation of serum anti-Mullerian hormone concentration in ovulatory intrauterine insemination Reproductive BioMedicine 2010;20(5):582–7. a preliminary study. 4. Lekamge DN, Barry M, Kolo M, et al. Anti-müllerian hormone as a predictor of IVF outcome. Reprod Biomed 2007;14(5):602–10.
  3. Broer SL, Mol BWJ, Hendriks D, et al. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009;91(3):705–14.
  4. Nardo LG, Yates AP, Roberts SA, et al. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non- obese subfertile women with and without polycystic ovary 2009;24(11):2917–23. Human Reproduction 7. Van Rooij IA, Tonkelaar I, Broekmans FJ, et al. Anti- mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11(6):601-6.
  5. Elgindy EA, El-Haieg DO, El-Sabaey A. Anti- müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil Steril 2008;89(6):1670–6.
  6. Hall JE, Welt CK, and Cramer DW. İnhibin A and İnhibin B reflect ovarian fuction in assisted reproduction but are less useful predicting outcome. Hum Reprod 1999;14(2):409-15.
  7. Bancsi LF, Huijs AM, Den Quden CT, et al. Basal follicle stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril 2000;73(3):552-7.
  8. Broer SL, Mol BW, Hendriks D, et al. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009;91(3):705-12.
  9. Hazout A, Bouchard P, Seifer DB, et al. Serum anti mullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 2004;82(5):1323–9.
  10. Eldar-Geva T, Ben-Chetrit A, Spitz IM, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outco